Treatment Options for Constipation
Start with osmotic laxatives (polyethylene glycol or lactulose) or stimulant laxatives (senna or bisacodyl) as first-line pharmacological therapy, combined with non-pharmacological measures including increased fluid intake and physical activity. 1, 2
Initial Assessment
Before initiating treatment, evaluate for reversible causes and severity:
- Assess for treatable causes: hypercalcemia, hypokalemia, hypothyroidism, diabetes mellitus, and medication-induced constipation 1
- Perform physical examination: abdominal examination, perineal inspection, and digital rectal examination to identify impaction or obstruction 1, 2
- Check labs if clinically indicated: corrected calcium and thyroid function 1, 2
- Consider plain abdominal X-ray to evaluate fecal loading extent and exclude bowel obstruction 1, 2
Non-Pharmacological Management (First-Line for All Patients)
- Increase fluid intake to adequate levels 1, 2
- Increase physical activity and mobility within patient's capabilities, even bed-to-chair transfers 1, 2
- Optimize toileting conditions: ensure privacy, comfort, and proper positioning (small footstool can facilitate defecation) 1, 2
- Add dietary fiber (25 g/day) only if fluid intake is adequate; fiber is effective for simple constipation but evidence for pain reduction is mixed 1, 2, 3
- Consider abdominal massage particularly for patients with neurogenic problems 1, 2
Important caveat: Bulk laxatives like psyllium are NOT recommended for opioid-induced constipation 1 and compounds like Metamucil are unlikely to control opioid-induced constipation 1
Pharmacological Treatment Algorithm
Step 1: First-Line Laxatives
Osmotic laxatives (preferred):
- Polyethylene glycol (PEG) 1, 2
- Lactulose 30-60 mL daily 1, 2
- Magnesium hydroxide 30-60 mL daily or magnesium citrate 1
OR Stimulant laxatives:
- Senna (docusate combination: 2 tablets every morning, maximum 8-12 tablets per day) 1, 2
- Bisacodyl 10-15 mg, 2-3 times daily 1, 2
- Sodium picosulfate 1, 2
Treatment goal: One non-forced bowel movement every 1-2 days 1
Caution: Magnesium salts can cause hypermagnesemia; use cautiously in renal impairment 1, 2
Step 2: If Constipation Persists
- Reassess for obstruction and impaction 1
- Add additional laxative agents from different classes 1
- Consider prokinetic agent (metoclopramide 10-20 mg PO 3-4 times daily) if gastroparesis suspected 1
Step 3: For Fecal Impaction
- Glycerine suppositories or bisacodyl suppository daily 1
- Manual disimpaction (digital fragmentation and extraction) 1, 2
- Fleet, saline, or tap water enema 1
Contraindications for enemas: neutropenia, thrombocytopenia, paralytic ileus, intestinal obstruction, recent colorectal/gynecological surgery, recent anal/rectal trauma, severe colitis, toxic megacolon, undiagnosed abdominal pain, or recent pelvic radiotherapy 1
Opioid-Induced Constipation (Special Considerations)
- Prophylactic laxatives are mandatory when starting opioids (unless pre-existing diarrhea) 1, 2
- Increase laxative dose when increasing opioid dose 1
- Avoid bulk laxatives like psyllium for opioid-induced constipation 1
If Standard Laxatives Fail:
Peripherally-acting μ-opioid receptor antagonists (PAMORAs):
- Methylnaltrexone 0.15 mg/kg subcutaneously every other day (maximum once daily) for opioid-induced constipation unresponsive to standard therapy 1, 2
- Contraindications: postoperative ileus or mechanical bowel obstruction 1
- Naloxegol is another option for chronic opioid use 1
Alternative agents:
- Lubiprostone (prostaglandin analog) effective for opioid-induced constipation in chronic non-cancer pain 1
- Linaclotide (guanylate cyclase-C agonist) effective for IBS-associated and chronic idiopathic constipation 1
Special Populations
Elderly Patients
- Pay particular attention to assessment 1, 2
- Ensure toilet access especially with decreased mobility 1, 2
- Provide dietetic support and manage decreased food intake 1, 2
- Optimize toileting: attempt defecation twice daily, 30 minutes after meals, strain no more than 5 minutes 1, 2
- PEG 17 g/day is safe and effective 2
- Avoid liquid paraffin in bedridden patients or those with swallowing disorders due to aspiration risk and lipoid pneumonia 2
Cancer Patients
- Constipation affects approximately 50% of advanced cancer patients 2
- Discontinue non-essential constipating medications 2
- Monitor for electrolyte imbalances when using diuretics or cardiac glycosides concomitantly 2
Key Clinical Pitfalls
- Do not rely on fiber alone for opioid-induced constipation—it is ineffective 1
- Higher fiber doses (>10 g/day) and longer treatment duration (≥4 weeks) are needed for effectiveness in chronic constipation 3
- Psyllium and pectin are the most effective fiber types when fiber is appropriate 3
- Always rule out obstruction before escalating laxative therapy 1
- Individualize laxative choice based on cardiac/renal comorbidities and medication interactions 2